Status: Recruiting
Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
This is a Phase Ib, randomized, double-blind, placebo-controlled clinical study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of Efsubaglutide Alfa Injection following multiple-dose administration in Chinese adolescent participants with obesity.
Participants needed: 36
Trial details
Phase: Phase 1Age: 12-17Biological sex: AllType: InterventionalSponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.Updated: Jul 30, 2026Locations: 5
Eligibility criteria
1. Informed consent must be obtained from the participant's parent or legally au... [+6]
1. Pre-pubertal participants (Tanner Stage I). [+20]